1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > The New Age of Regenerative Medicine : Why Stem Cell Therapy?

The New Age of Regenerative Medicine : Why Stem Cell Therapy?

  • September 2015
  • -
  • Frost & Sullivan
  • -
  • 60 pages

The New Age of Regenerative Medicine : Why Stem Cell Therapy?


Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the ageing population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.

Key Findings

Regenerative Medicine (RM) represents a new human-health paradigm with the potential to resolve unmet medical needs by addressing the underlying causes of diseases.
- The global regenerative medicine industry was worth $ billion in 2013 and is expected to reach $ billion in 2020, growing at a robust Cumulative Annual Growth Rate (CAGR) of % (2013–2020).
- Globally, there are over companies focussed on regenerative medicine. The United States has the most registered RM companies, followed by the United Kingdom, Germany, and Japan. - There are over 80 public RM companies in the world with approximately $ billion of market capital.
- In the cell therapy segment, non-healing wounds and skin wounds have the highest market share ( %); this is closely followed by the musculoskeletal sector at %.
- The Asia-Pacific stem cell therapy research market was valued at $ million in 2014 and is projected to increase to $ million by 2018.
- Rapidly growing medical tourism, contract research outsourcing, and a rising population of patients with neurological and other chronic conditions are some of the factors driving the Asian stem cells market.

Table Of Contents

The New Age of Regenerative Medicine : Why Stem Cell Therapy?
1 THE NEW AGE OF REGENERATIVE MEDICINE

Executive Summary
1 Key Findings
2 Key Questions This Study Will Answer
3 Regenerative Medicine Industry—Where We Stand Today
4 Regenerative Medicine Industry—Where We Stand Today
5 Regenerative Medicine Industry—Key Stakeholders

The New Age of Regenerative Medicine—An Overview
1 Definition—Regenerative Medicine
2 Regenerative Medicine—Market Segmentation
3 Why is Regenerative Medicine Important to the Future of Healthcare?
4 Market Size and Growth—Regenerative Medicine
5 Geographical Overview for Regenerative Medicine Companies
6 Total Regenerative Medicine Industry
7 Definitions—Cell Therapy and Stem Cell Therapy
8 Cell Therapy—Commercially Available Products by Therapy
9 Overview of Competing Products—By Development and Key Participants
10 Commercially Available Primary Cell Therapy and Allograft Products
11 Commercially Available Primary Cell Therapy and Allograft Products
12 Cellular Dynamics International (CDI), Madison, Wisconsin
13 Orthofix International, Lewisville, Texas
14 Capricor Therapeutics, Beverly Hills, California
15 Big Pharmaceuticals and Regenerative Medicine

Stem Cell Manufacturing Facilities—Market Dynamics
1 Market Drivers and Restraints for Stem Cell Manufacturing

Stem Cell Consumers
1 Stem Cell Consumer Information—The United States
2 Stem Cell Consumer Information—Global

Future Trends
1 Future Trends
2 Market Opportunities

Regenerative Medicine Industry—Mergers, Acquisitions, and Partnership Assessment
1 Global Partnerships and Deals for Regenerative Medicine
2 Key Global Partnerships and Deals for Regenerative Medicine

Regenerative Medicine Industry—Funding Scenario
1 Regenerative Medicine Market—Funding Scenario

Overview of Regenerative Medicine in Asia-Pacific
1 Regenerative Medicine—Asia-Pacific Market Overview
2 Regenerative Medicine—Leading APAC Countries
3 Regenerative Medicine—Leading APAC Countries
4 Regenerative Medicine—Lifecycle for Leading APAC Countries
5 Regenerative Medicine—South Korea
6 Regenerative Medicine—China
7 Regenerative Medicine—Japan
8 Regenerative Medicine—Singapore
9 Regenerative Medicine—Key Market Access Barriers
10 Successful Stem Cell Therapy Company—MEDIPOST Co, Ltd
11 Successful Stem Cell Therapy Company—Mesoblast Ltd

Conclusion
1 The Last Word
2 Legal Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative ...

Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

  • $ 5000
  • Industry report
  • August 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

REPORT DESCRIPTION This report analyzes the current and future prospects of the regenerative medicine across the globe. Regenerative medicine is considered as an emerging field of medical science that ...

Tissue Engineering - Global Market Outlook (2016-2022)

Tissue Engineering - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Tissue Engineering market is expected to grow from $6.24 billion in 2015 to reach $14.86 billion by 2022 with a CAGR of 13.2%. Growing usage of tissue engineering ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.